AXIN2 and colorectal carcinoma: AXIN2, on the other hand, has a recurring frameshift mutation in exon 7 across multiple tumour types [44], particularly in CRC and stomach cancer, see Figure 3C. This gives rise to a truncated protein, stabilized β-catenin, and activated WNT signalling.